Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections (NCT06513806) | Clinical Trial Compass
CompletedPhase 4
Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections
Egypt330 participantsStarted 2024-08-01
Plain-language summary
Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean Sections
Who can participate
Age range18 Years – 45 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* elective for caesarian section presence of post-spinal shivering, defined as involuntary muscle contractions occurring within operative and early recovery period after cesarean delivery.
* Age 18 - 45
Exclusion Criteria
* Inability to provide informed consent.
* Previous allergies or sensitivities to granisetron or pethidine.
* Current use of medications that may interact with granisetron or pethidine.
* Presence of other conditions that may contraindicate the use of granisetron or pethidine, such as known liver or kidney disease.
* Patients who are too short (\<140 cm) or too tall (\>190 cm)